CA-GLOBALPLATFORM
24.5.2023 08:01:30 CEST | Business Wire | Press release
GlobalPlatform, a leading digital standards organization, has launched a broad-reaching initiative to drive engagement across security experts in the full automotive value chain and adjacent digital services. As a leader in delivering specifications and certifications for secure digital services — over 70 billion GlobalPlatform secure components deployed worldwide —GlobalPlatform is now addressing emerging automotive regulations such as new vehicle type approvals and the shift towards vehicles as a service. GlobalPlatform’s automotive initiative will optimize and accelerate the deployment of secure components, trusted digital architecture, security APIs, and security lifecycle management within the automotive sector. This initiative is being led by a dedicated Automotive Task Force to foster the alignment of GlobalPlatform technologies with automotive use cases. GlobalPlatform has also partnered with automotive standards organizations and formed the Cybersecurity Vehicle Forum to unite the automotive ecosystem in optimizing cybersecurity for vehicles.
“Recent automotive cybersecurity regulations and emerging trends like the move towards autonomous driving and flexible mobility solutions are requiring car manufacturers to become more agile and adaptable in the deployment of secure vehicle services. GlobalPlatform’s secure component technologies support the automotive sector’s compliance with these new regulations and requirements,” said Ana Tavares Lattibeaudiere, Executive Director, GlobalPlatform.
In addition to launching the Automotive Task Force, GlobalPlatform established a cooperative agreement with the Society of Automotive Engineers (SAE) to work on the harmonization of hardware-based secure execution environments in automotive. GlobalPlatform has also partnered with AUTOSAR to coordinate the alignment of secure component standards and specifications for automotive. Furthermore, GlobalPlatform has joined the Auto-ISAC community and has an active memorandum of understanding (MoU) with the Car Connectivity Consortium. These alliances will ensure coordination and alignment on common requirements with key automotive and cybersecurity organizations.
“GlobalPlatform is committed to working with the full automotive value chain to address current automotive security requirements while also focusing on developing interoperable, secure components to meet emerging vehicle standards,” said Gil Bernabeu, Chief Technology Officer, GlobalPlatform.
Another key aspect of GlobalPlatform’s automotive initiative is the launch of the Cybersecurity Vehicle Forum, which will strengthen engagement and cooperation between GlobalPlatform members and the wider automotive ecosystem. The Forum plays an invaluable role in identifying and prioritizing automotive industry requirements to deliver secure component services that span the lifecycle of a vehicle. With global events planned throughout the year, the Cybersecurity Vehicle Forum gives car manufacturers, component companies, automotive regulators, and others a platform to explore the current and future automotive use cases for trusted services and hardware-based secure services.
GlobalPlatform welcomes existing and new member contributions in developing the next generation of automotive security standards and invites the automotive ecosystem to participate in the Cybersecurity Vehicle Forum.
Contact automotive@globalplatform.org to learn more.
About GlobalPlatform
GlobalPlatform is a technical standards organization that enables the efficient launch and management of innovative, secure-by-design digital services and devices, which deliver end-to-end security, privacy, simplicity, and convenience to users. It achieves this by providing standardized technologies and certifications that empower technology and service providers to develop, certify, deploy, and manage digital services and devices in line with their business, security, regulatory and data protection needs. GlobalPlatform technologies are used in billions of smart cards, smartphones, wearables and other connected IoT devices.
GlobalPlatform standardized technologies and certifications are developed through effective industry-driven collaboration, led by multiple diverse member companies working in partnership with industry and regulatory bodies and other interested parties from around the world.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230523005955/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom